ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Tarsons Products (TARSONS.NSE)
Tarsons Products share price today, ATLAS forecast and fair value
Healthcare · Medical Instruments & Supplies · National Stock Exchange of India · India
₹298.30▼ -0.57%
Prices as of Oct 26, 2026 · INR
Chance of rising in 1 month
48%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Tarsons Products in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Tarsons Products
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Tarsons Products a 48% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between ₹271.69 and ₹324.18; in 9 out of 10, between ₹232.31 and ₹379.13. Estimated annual volatility is 54%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- ₹16.8B
- Market cap (USD)
- $177M
- P/E ratio
- 158.5
- 52-week high
- ₹375.00
- 52-week low
- ₹164.45
- Revenue (12 months)
- ₹4.4B
- Operating margin
- -0.9%
- Net margin
- 2.5%
- Beta
- 0.30
What this means
ATLAS does not publish a fair value for TARSONS.NSE right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks TARSONS.NSE has traded between ₹164.45 and ₹375.00. Today it is 20.5% below that high and 81% above its low.
On the business: net margin is 2.5%; it trades at 158.5 times earnings.
Its beta is 0.30: it tends to move less than the market.
About the company
Tarsons Products Ltd. is an Indian company primarily engaged in the manufacture and supply of laboratory equipment and scientific products.
Want to see everything about Tarsons Products?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does Tarsons Products do?
Tarsons Products Ltd. is an Indian company primarily engaged in the manufacture and supply of laboratory equipment and scientific products.
What is the chance TARSONS.NSE goes up next month?
48%: close to a coin flip. In half of the simulated outcomes, TARSONS.NSE ends the month between ₹271.69 and ₹324.18.
How big is Tarsons Products and what is its P/E ratio?
Tarsons Products's market capitalization is ₹16.8B. Its price-to-earnings (P/E) ratio is 158.5: you pay ₹158.5 for each ₹1.00 of yearly earnings.
How volatile is TARSONS.NSE?
ATLAS estimates annual volatility at 54%. In a typical month, half of the outcomes end between ₹271.69 and ₹324.18.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer